Since the 1960s, the hallucinogenic drug ibogaine has piqued interest as a potential treatment for opioid addiction, fueled by limited experimental evidence and anecdotal claims by those who claim ...

The current gold standard therapy for opioid addiction is a "replacement therapy" where a less efficacious opioid is given to the patient. However, patients often have difficulty abstaining from ...

Scientists have developed two new drug candidates for potentially treating addiction and depression, modeled on the pharmacology of a traditional African psychedelic plant medicine called ibogaine. At ...

Chemists have created a highly reactive chemical compound that has eluded scientists for more than 120 years. The discovery could lead to new drug treatments, safer agricultural products, and better ...

Enveric receives its first patent for psychedelic-derived mescaline compounds. Non-hallucinogenic drugs aim to help with addiction, ADHD and anxiety. See what Wall Street is buying with instant access ...